Clinical Trial Update: Chemoradiotherapy for Recurrent T1G3 Bladder Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating chemoradiotherapy for recurrent T1G3 bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Assiut University | Conditions: Bladder Cancer | Phase 4 | Status: UNKNOWN